Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Oritavancin CAS 171099-57-3

Oritavancin CAS 171099-57-3

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 171099-57-3

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS No::
171099-57-3
Appearance::
White Powder
Molecular Formula::
C86H97Cl3N10O26
Molecular Weight::
1793.1
EINECS NO::
N/A
MDL NO::
MFCD12756396
CAS No::
171099-57-3
Appearance::
White Powder
Molecular Formula::
C86H97Cl3N10O26
Molecular Weight::
1793.1
EINECS NO::
N/A
MDL NO::
MFCD12756396
Oritavancin CAS 171099-57-3

Product Description:

Product Name:oritavancin CAS 171099-57-3

 

Synonyms:

(4R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-a-L-arabinohexopyranosyl)-N3-(p-(p-chlorophenyl)benzyl)vancomycin;

 

Chemical & Physical Properties

Appearance:

Assay: 99%+

Pka:2.93±0.70

Solubility:Soluble in DMSO

Density:1.59±0.1g/cm3

 

Application

The FDA has approved the antibiotic Orbactiv (oritavancin, Orivin, IV) injection for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSIs) caused by sensitive Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA).

 

If you are interested in our products or have any questions, please feel free to contact us!

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.